Last updated on March 2014

Asthma


Brief description of study

Asthma

Detailed Study Description

A Randomized, Double Blind, Double Dummy, Placebo Controlled, Parallel Group, 12 Week Clinical Study to Assess the Efficacy and Safety of 80 or 160 mcg/Day of Beclomethasone Dipropionate Delivered via Breath Actuated Inhaler (BAI) or Metered Dose Inhaler (MDI) in Pediatric Patients 5 Through 11 Years of Age with Persistent Asthma

Clinical Study Identifier: TX138006

Contact Investigators or Research Sites near you

Start Over

Vital Prospects Clinical Research Institute, ...

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »